Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 USD | -0.68% | -2.81% | +155.99% |
Jun. 03 | Humacyte Insider Sold Shares Worth $1,561,605, According to a Recent SEC Filing | MT |
May. 30 | Certain Common Stock of Humacyte, Inc. are subject to a Lock-Up Agreement Ending on 30-MAY-2024. | CI |
Chart calendar Humacyte, Inc.
Upcoming events on Humacyte, Inc.
Past events on Humacyte, Inc.
2024-06-06 01:00 pm | Jefferies Global Healthcare Conference |
2024-05-20 | Benchmark Healthcare House Virtual Conference |
2024-05-20 05:00 pm | H.C. Wainwright BioConnect Investor Conference - Fireside Chat |
2024-05-10 08:00 am | Q1 2024 Earnings Call |
2024-05-10 07:00 am | Q1 2024 Earnings Release |
2024-03-28 08:00 am | Investor Meeting - Key Opinion Leader |
2024-03-22 08:00 am | Q4 2023 Earnings Call |
2024-03-22 07:00 am | Q4 2023 Earnings Release |
2024-03-04 12:50 pm | TD Cowen Health Care Conference |
2023-11-30 08:00 am | Piper Sandler Healthcare Conference |
2023-11-15 09:15 am | Sidoti Microcap Virtual Conference |
2023-11-09 04:30 pm | Q3 2023 Earnings Call |
2023-11-09 04:01 pm | Q3 2023 Earnings Release |
2023-09-28 01:15 pm | Cantor Global Healthcare Conference |
2023-09-20 03:00 pm | Investor Meeting - KOL |
2023-09-12 08:00 am | Investor Meeting - Key Opinion Leader |
2023-08-14 08:00 am | Q2 2023 Earnings Call |
2023-08-14 07:00 am | Q2 2023 Earnings Release |
2023-06-09 10:00 am | Jefferies Global Healthcare Conference |
2023-06-07 08:00 am | Annual General Meeting |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,26 1,22 3.67% | 1,57 1,77 -11.47% | 0,00 0,05 - | 2,60 |
EBITDA Million USD | Released Forecast Spread | -75,0 -72,6 -3.34% | -82,6 -75,4 -9.49% | -85,5 -96,7 11.58% | -81,6 |
EBIT Million USD | Released Forecast Spread | -81,2 -81,3 0.1% | -84,6 -87,9 3.76% | -100 -98,9 -1.13% | -110 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,5 -90,0 70.59% | -12,0 -32,5 63.23% | -111 -109 -1.7% | -116 |
Net income Million USD | Released Forecast Spread | -26,5 -84,9 68.83% | -12,0 -33,0 63.71% | -111 -109 -1.32% | -113 |
EPS USD | Released Forecast Spread | -0,66 -1,60 58.75% | -0,12 -0,32 62.5% | -1,07 -1,06 -1.08% | -0,98 |
Announcement Date | 29/03/22 | 24/03/23 | 22/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,23 0,20 13.94% | 1,30 0,20 536.19% | 0,03 0,20 -84.77% | 0,00 0,20 - | 0,00 0,15 - | 0,00 0,07 - | 0,00 0,07 - | 0,00 0,05 - | 0,00 0,00 - | 0,00 | 0,48 | 2,46 | 3,94 | 5,06 |
EBITDA Million USD | Released Forecast Spread | -18,2 -19,4 6.31% | -15,0 -19,6 23.37% | -20,0 -20,1 0.58% | -20,3 -22,2 8.35% | ||||||||||
EBIT Million USD | Released Forecast Spread | -21,8 -21,7 -0.47% | -18,5 -22,5 17.62% | -23,5 -22,2 -5.77% | -20,8 -24,1 13.75% | -22,5 -21,6 -4.29% | -26,7 -22,7 -17.84% | -24,6 -26,5 7.03% | -26,2 -25,1 -4.46% | -26,6 -25,9 -2.62% | -27,1 | -28,2 | -28,1 | -28,2 | -27,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,8 -21,5 7.92% | 36,9 -22,8 261.78% | -25,3 -22,3 -13.52% | -3,72 -24,3 84.68% | -37,0 -21,8 -69.57% | -22,7 -22,9 0.83% | -26,0 -26,6 2.4% | -25,1 -25,2 0.19% | -31,9 -25,8 -23.75% | -28,0 | -29,5 | -29,5 | -28,7 | -28,0 |
Net income Million USD | Released Forecast Spread | -19,8 -21,5 7.92% | 36,9 -22,8 261.78% | -25,3 -22,3 -13.49% | -3,72 -24,2 84.61% | -37,0 -21,7 -70.35% | -22,7 -22,8 0.32% | -26,0 -26,6 2.2% | -25,1 -25,3 0.67% | -31,9 -25,8 -23.75% | -27,3 | -28,4 | -28,3 | -28,7 | -28,0 |
EPS USD | Released Forecast Spread | -0,19 -0,21 7.32% | 0,35 -0,22 259.09% | -0,25 -0,22 -16.28% | -0,04 -0,24 82.98% | -0,36 -0,21 -71.43% | -0,22 -0,22 0% | -0,25 -0,26 3.85% | -0,24 -0,24 1.76% | -0,29 -0,23 -28.89% | -0,24 | -0,24 | -0,24 | -0,24 | -0,24 |
Announcement Date | 13/05/22 | 12/08/22 | 10/11/22 | 24/03/23 | 12/05/23 | 14/08/23 | 09/11/23 | 22/03/24 | 10/05/24 | - | - | - | - | - |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Humacyte, Inc.
2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HUMA Stock
- Calendar Humacyte, Inc.